• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用人胚胎干细胞衍生心肌细胞的心肌再生策略。

Myocardial regeneration strategies using human embryonic stem cell-derived cardiomyocytes.

作者信息

Capi Oren, Gepstein Lior

机构信息

Sohnis Family Research Laboratory for the Regeneration of Functional Myocardium, Rappaport Family Institute for Research in the Medical Sciences, Israel.

出版信息

J Control Release. 2006 Nov 28;116(2):211-8. doi: 10.1016/j.jconrel.2006.06.027. Epub 2006 Jun 29.

DOI:10.1016/j.jconrel.2006.06.027
PMID:17005287
Abstract

Regenerative medicine is a new biomedicine discipline that takes advantage of the recent advancements in the fields of stem cell biology, molecular biology, and tissue engineering to derive tissue substitutes, in an attempt to replace or modify the function of diseased organs. The heart represents an attractive candidate for these emerging technologies since adult cardiac tissue has limited regenerative capacity. Consequentially, myocardial cell replacement therapy has emerged as a novel therapeutic paradigm for restoration of the myocardial electromechanical function. This innovative strategy has been significantly hampered, however, by the paucity of cell sources for human cardiomyocytes. The recent establishment of the human embryonic stem cell (hESC) lines may provide a possible solution for this cell-sourcing problem. These unique pluripotent cell lines can be propagated in the undifferentiated state in culture and coaxed to differentiate into cell derivatives of all three germ layers, including cardiomyocytes. This review will describe the hESC system, their differentiation into cardiomyocytes, and the structural and functional characterization of these cardiac lineage derivatives. The potential applications of this unique differentiating system in several research areas will be discussed with special emphasis on the steps required to fully harness their unique potential in the emerging field of cardiovascular regenerative medicine.

摘要

再生医学是一门新兴的生物医学学科,它利用干细胞生物学、分子生物学和组织工程领域的最新进展来获取组织替代物,试图替代或改善患病器官的功能。心脏是这些新兴技术的一个有吸引力的应用对象,因为成体心脏组织的再生能力有限。因此,心肌细胞替代疗法已成为恢复心肌机电功能的一种新型治疗模式。然而,这种创新策略因人类心肌细胞的细胞来源匮乏而受到严重阻碍。人胚胎干细胞(hESC)系的近期建立可能为这个细胞来源问题提供一个解决方案。这些独特的多能细胞系可以在培养中以未分化状态增殖,并被诱导分化为包括心肌细胞在内的所有三个胚层的细胞衍生物。本综述将描述hESC系统、它们向心肌细胞的分化以及这些心脏谱系衍生物的结构和功能特征。将讨论这个独特的分化系统在几个研究领域的潜在应用,特别强调在心血管再生医学新兴领域中充分发挥其独特潜力所需的步骤。

相似文献

1
Myocardial regeneration strategies using human embryonic stem cell-derived cardiomyocytes.使用人胚胎干细胞衍生心肌细胞的心肌再生策略。
J Control Release. 2006 Nov 28;116(2):211-8. doi: 10.1016/j.jconrel.2006.06.027. Epub 2006 Jun 29.
2
Human embryonic stem cells for cardiomyogenesis.用于心肌生成的人类胚胎干细胞。
J Mol Cell Cardiol. 2008 Oct;45(4):462-74. doi: 10.1016/j.yjmcc.2008.08.008. Epub 2008 Aug 30.
3
Cardiovascular therapeutic aspects of cell therapy and stem cells.细胞治疗和干细胞的心血管治疗方面
Ann N Y Acad Sci. 2006 Oct;1080:415-25. doi: 10.1196/annals.1380.030.
4
Regenerating the heart using human embryonic stem cells--from cell to bedside.利用人类胚胎干细胞再生心脏——从细胞到临床应用
Isr Med Assoc J. 2006 Mar;8(3):208-14.
5
Differentiation pathways in human embryonic stem cell-derived cardiomyocytes.人胚胎干细胞衍生心肌细胞的分化途径。
Ann N Y Acad Sci. 2005 Jun;1047:50-65. doi: 10.1196/annals.1341.005.
6
Potential applications of human embryonic stem cell-derived cardiomyocytes.人胚胎干细胞衍生心肌细胞的潜在应用。
Ann N Y Acad Sci. 2004 May;1015:285-98. doi: 10.1196/annals.1302.024.
7
Innovation in basic science: stem cells and their role in the treatment of paediatric cardiac failure--opportunities and challenges.基础科学领域的创新:干细胞及其在小儿心力衰竭治疗中的作用——机遇与挑战
Cardiol Young. 2009 Nov;19 Suppl 2:74-84. doi: 10.1017/S104795110999165X.
8
Cell sources for cardiovascular tissue regeneration and engineering.用于心血管组织再生与工程的细胞来源。
Thorac Cardiovasc Surg. 2009 Mar;57(2):63-73. doi: 10.1055/s-2008-1039235. Epub 2009 Feb 24.
9
Another possible cell source for cardiac regenerative medicine: reprogramming adult fibroblasts to cardiomyocytes and endothelial progenitor cells.另一种用于心脏再生医学的可能的细胞来源:将成纤维细胞重编程为心肌细胞和内皮祖细胞。
Med Hypotheses. 2011 Mar;76(3):365-7. doi: 10.1016/j.mehy.2010.10.041. Epub 2010 Nov 18.
10
Global expression profile of highly enriched cardiomyocytes derived from human embryonic stem cells.源自人类胚胎干细胞的高度富集心肌细胞的全局表达谱
Stem Cells. 2009 Sep;27(9):2163-74. doi: 10.1002/stem.166.

引用本文的文献

1
Automated grouping of action potentials of human embryonic stem cell-derived cardiomyocytes.人胚胎干细胞来源心肌细胞动作电位的自动分组
IEEE Trans Biomed Eng. 2014 Sep;61(9):2389-95. doi: 10.1109/TBME.2014.2311387.
2
Mesenchymal stem cells from umbilical cord tissue as potential therapeutics for cardiomyodegenerative diseases - a review.脐带组织间充质干细胞作为心肌退行性疾病的潜在治疗方法——综述
Int J Mol Cell Med. 2012 Summer;1(3):119-32.
3
Electrophysiological and contractile function of cardiomyocytes derived from human embryonic stem cells.
人胚胎干细胞来源的心肌细胞的电生理和收缩功能。
Prog Biophys Mol Biol. 2012 Oct-Nov;110(2-3):178-95. doi: 10.1016/j.pbiomolbio.2012.07.012. Epub 2012 Aug 7.
4
Increased cardiogenesis in P19-GFP teratocarcinoma cells expressing the propeptide IGF-1Ea.表达前肽 IGF-1Ea 的 P19-GFP 畸胎瘤细胞中的心发生增加。
Biochem Biophys Res Commun. 2011 Dec 16;416(3-4):293-9. doi: 10.1016/j.bbrc.2011.11.028. Epub 2011 Nov 12.
5
Stem Cell Therapy in Acute Myocardial Infarction: A Pot of Gold or Pandora's Box.急性心肌梗死中的干细胞治疗:是金饭碗还是潘多拉魔盒。
Stem Cells Int. 2011;2011:536758. doi: 10.4061/2011/536758. Epub 2011 May 11.
6
Is tissue engineering a new paradigm in medicine? Consequences for the ethical evaluation of tissue engineering research.组织工程是医学领域的一种新范式吗?对组织工程研究伦理评估的影响。
Med Health Care Philos. 2009 Nov;12(4):459-67. doi: 10.1007/s11019-009-9192-0. Epub 2009 Jul 24.
7
Pre-transplantation specification of stem cells to cardiac lineage for regeneration of cardiac tissue.用于心脏组织再生的干细胞向心脏谱系的移植前定向分化
Stem Cell Rev Rep. 2009 Mar;5(1):51-60. doi: 10.1007/s12015-009-9050-8. Epub 2009 Jan 30.
8
Cell therapy in congestive heart failure.充血性心力衰竭的细胞治疗。
J Zhejiang Univ Sci B. 2007 Sep;8(9):647-60. doi: 10.1631/jzus.2007.B0647.